Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
BEAST is a venture capital firm based in the United Kingdom, founded to support early-stage companies in the UK and Continental Europe. The firm specializes in Seed Stage investments, focusing on breakthrough engineering and applied science. They manage a portfolio of 16 companies, emphasizing technologies with significant health, climate, or societal impact.
BEAST invests in startups engaged in breakthrough engineering and applied science across various sectors, including healthcare, climate, and biotechnology. Their investment strategy is centered on Seed Stage companies, particularly those developing deep technologies that offer impactful solutions. Typical check sizes and specific funding amounts are not disclosed.
Notable portfolio companies include Q Bio, which develops technology for early disease detection; TRACE GENOMICS, an analytics engine for soil value maximization; and Sparrho, which combines human and AI for tailored science news. Other companies include Inoviv, Ochre Bio, and LABGENIUS, focusing on biomarker tests, genomic medicines, and protein-based therapeutics, respectively.
Submit through their form at beast.vc.
BEAST typically leads Seed Stage rounds, providing initial capital and support to early-stage companies.
BEAST is open to follow-on investments, particularly for companies that demonstrate significant growth and potential for impact.
The specific size of BEAST's current fund is not publicly disclosed, but they focus on Seed Stage investments across their portfolio.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.